Latest News of KMDA
Kamada Ltd (KMDA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Increased EBITDA ...
By Yahoo! Finance |
1 week ago
The company reported strong growth for Kedrab and Cytogam products, with an estimated market share of 40-50%. InnovAte trial enrollment is at 50%, with ongoing discussions with the FDA....
Kamada Ltd. (KMDA): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
By Yahoo! Finance |
2 months ago
The article discusses Kamada Ltd. and its position among cheap pharmaceutical stocks. It highlights the evolving pharma industry, the rise of biotechnology, and factors influencing firm valuations. Ka...